Finance

Lists
Q3 2026 earnings • 9:00 AM today
See details
6472:TPE
Bora Pharmaceuticals Co Ltd
NT$402.00
+0.25%
(+1.00) 1D
Nov 13, 1:30:19 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6472...
Open
NT$402.50
High
NT$416.00
Low
NT$398.00
Mkt. cap
51.46B
Avg. vol.
686.57K
Volume
764.44K
P/E ratio
32.99
52-wk high
NT$646.00
52-wk low
NT$330.50
EPS
NT$12.19
No. of employees
36
Open
NT$402.50
High
NT$416.00
Low
NT$398.00
Mkt. cap
51.46B
Avg. vol.
686.57K
Volume
764.44K
P/E ratio
32.99
52-wk high
NT$646.00
52-wk low
NT$330.50
EPS
NT$12.19
No. of employees
36
News stories
From web sources and news partners
About Bora Pharmaceuticals Co Ltd
CEOBobby Sheng
Employees36
Founded2007
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebora-corp.com
Awaiting results...
Call Time: Today, 9:00 AM
Fiscal period
Q3 2026
- / NT$5.23
Revenue / Est. (TWD)
- / 6.28B
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.81B
4.86B
4.00B
5.89B
Cost of goods sold
2.63B
3.09B
2.56B
3.46B
Cost of revenue
2.63B
3.09B
2.56B
3.46B
Research and development expenses
147.09M
181.25M
167.93M
190.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
961.21M
1.03B
866.09M
1.25B
Operating expense
1.11B
1.22B
1.04B
1.44B
Total operating expenses
3.74B
4.30B
3.59B
4.90B
Operating income
1.06B
556.34M
407.24M
986.64M
Other non operating income
36.54M
15.19M
24.01M
-15.28M
EBT including unusual items
895.42M
809.67M
221.15M
813.10M
EBT excluding unusual items
926.44M
375.02M
222.24M
788.94M
Income tax expense
73.70M
381.93M
174.25M
205.59M
Effective tax rate
8.23%
47.17%
78.79%
25.28%
Other operating expenses
396.00K
1.24M
1.37M
-
Net income
633.61M
331.76M
25.84M
555.76M
Net profit margin
13.18%
6.83%
0.65%
9.44%
Earnings per share
4.99
2.78
0.20
4.24
Interest and investment income
2.67M
10.49M
6.25M
11.16M
Interest expense
-125.12M
-122.01M
-113.73M
-124.33M
Net interest expenses
-122.44M
-111.52M
-107.48M
-113.17M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.28B
784.95M
634.54M
1.27B
Gain or loss from assets sale
-10.15M
1.32M
63.00K
2.00K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps